A mathematical model evaluating the timing of early diagnostic testing in HIV-exposed infants in South Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue 3, 2014, Pages 341-348

  Lilian, Rivka R ^a   Johnson, Leigh F ^b   Moolla, Haroon ^b   Sherman, Gayle G ^a,c,d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Early infant diagnosis; HIV; Mathematical model; Perinatal transmission

Indexed keywords

NEVIRAPINE; ZIDOVUDINE;

ALGORITHM; ARTICLE; CAREGIVER; CONTROLLED STUDY; DRUG EFFICACY; EARLY DIAGNOSIS; FEMALE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFANT MORTALITY; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; PERINATAL HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIMULATION; SOUTH AFRICAN; EPIDEMIOLOGY; HIV INFECTIONS; MALE; MORTALITY; NEWBORN; SOUTH AFRICA; THEORETICAL MODEL; TIME; VERTICAL TRANSMISSION;

EARLY DIAGNOSIS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MODELS, THEORETICAL; POLYMERASE CHAIN REACTION; SOUTH AFRICA; TIME FACTORS;

EID: 84922064859     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000307     Document Type: Article

References (57)

1. Bourne DE, Thompson M, Brody LL, et al. Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS. 2009; 23:101-106.
2. Marston M, Becquet R, Zaba B, et al. Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol. 2011;40:385-396.
3. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359: 2233-2244.
4. Lilian RR, Kalk E, Technau K, et al. Birth diagnosis of HIV infection in infants to reduce infant mortality and monitor for elimination of motherto- child transmission. Pediatr Infect Dis J. 2013;32:1080-1085.
5. National Department of Health of South Africa. Clinical Guidelines: PMTCT (Prevention of Mother-to-Child Transmission). Pretoria, South Africa; 2010.
6. National Department of Health of South Africa. The South African Antiretroviral Treatment Guidelines. Pretoria, South Africa; 2013.
7. Ahmed S, Kim MH, Sugandhi N, et al. Beyond early infant diagnosis: case finding strategies for identification of HIV-infected infants and children. AIDS. 2013;27(suppl 2):S235-S245.
8. Massyn N, Day C, Dombo M, et al, eds. District Health Barometer 2012/13. Durban, South Africa: Health Systems Trust; 2013.
9. Coetzee D, Hilderbrand K, Boulle A, et al. Effectiveness of the first districtwide programme for the prevention of mother-to-child transmission of HIV in South Africa. Bull World Health Organ. 2005;83:489-494.
10. van der Merwe K, Chersich MF, Technau K, et al. Integration of antiretroviral treatment within antenatal care in Gauteng Province, South Africa. J Acquir Immune Defic Syndr. 2006;43:577-581.
11. World Health Organization. Global Update on HIV Treatment 2013: Results, Impact and Opportunities. Geneva, Switzerland; 2013.
12. Sherman GG, Cooper PA, Coovadia AH, et al. Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings. Pediatr Infect Dis J. 2005;24:993-997.
13. Bryson YJ, Luzuriaga K, Sullivan JL, et al. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med. 1992; 327:1246-1247.
14. Dunn DT, Brandt CD, Krivine A, et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS. 1995;9:F7-F11.
15. Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243.
16. Kourtis AP, Bulterys M, Nesheim SR, et al. Understanding the timing of HIV transmission from mother to infant. JAMA. 2001;285:709-712.
17. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795-802.
18. Lilian RR, Kalk E, Bhowan K, et al. Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age. J Clin Microbiol. 2012;50:2373-2377.
19. Mphatswe W, Blanckenberg N, Tudor-Williams G, et al. High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis. AIDS. 2007;21:1253-1261.
20. Nielsen-Saines K, Watts DH, Veloso VG, et al. Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N Engl J Med. 2012;366:2368-2379.
21. Burgard M, Blanche S, Jasseron C, et al. Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis. J Pediatr. 2012;160:60-66e1.
22. Connolly MD, Rutstein RM, Lowenthal ED. Virologic testing in infants with perinatal exposure to HIV receiving multidrug prophylaxis. Pediatr Infect Dis J. 2013;32:196-197.
23. Shapiro DE, Balasubramanian R, Fowler MG, et al. Time to HIV DNAPCR positivity according to maternal/infant antiretroviral prophylactic regimen in non-breastfed HIV-infected infants in populations with predominantly non-B HIV subtype: a collaborative analysis of data from cohorts in Thailand, South Africa, Botswana and the United Kingdom [TUAB0203]. Paper presented at: 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 17-20, 2011; Rome, Italy.
24. World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Recommendations for a Public Health Approach. Geneva, Switzerland; 2013.
25. Johnson LF, Davies MA, Moultrie H, et al. The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: a model-based analysis. Pediatr Infect Dis J. 2012;31:474-480.
26. Johnson LF, Stinson K, Newell ML, et al. The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to motherto- child transmission of HIV. J Acquir Immune Defic Syndr. 2012;59: 417-425.
27. Actuarial Society of South Africa. ASSA2008 AIDS and Demographic Model. 2011.
28. National Department of Health of South Africa. Guidelines for the Management of HIV in Children. Pretoria, South Africa; 2010.
29. Goga AE, Dinh TH, Jackson DJ, et al. Evaluation of the effectiveness of the national prevention of mother-to-child transmission (PMTCT) programme measured at six weeks postpartum in South Africa, 2010. National Department of Health of South Africa and PEPFAR/US Centers for Disease Control and Prevention. Pretoria, South Africa: South African Medical Research Council; 2012.
30. Johnson LF. A Model of Paediatric HIV in South Africa; 2010. Available at: http://webdav.uct.ac.za/depts/epi/publications/documents/Paediatric-HIV-modelling5.pdf. Accessed November 19, 2013.
31. Rollins N, Mahy M, Becquet R, et al. Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in spectrum and other population-based models. Sex Transm Infect. 2012;88 (suppl 2):i44-51.
32. Moodley D, Moodley J, Coovadia H, et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 2003;187:725-735.
33. Chasela C, Chen YQ, Fiscus S, et al. Risk factors for late postnatal transmission of human immunodeficiency virus type 1 in sub-Saharan Africa. Pediatr Infect Dis J. 2008;27:251-256.
34. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004;351:217-228.
35. Shapiro RL, Thior I, Gilbert PB, et al. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-tochild HIV transmission in Botswana. AIDS. 2006;20:1281-1288.
36. Dabis F, Bequet L, Ekouevi DK, et al. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS. 2005;19:309-318.
37. National Breastfeeding Consultative Meeting. The Tshwane declaration of support for breastfeeding in South Africa. South Afr J Clin Nutr. 2011;24:214.
38. Coutsoudis A, Pillay K, Kuhn L, et al. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS. 2001;15:379-387.
39. Goga AE, Van Wyk B, Doherty T, et al. Operational effectiveness of guidelines on complete breast-feeding cessation to reduce mother-tochild transmission of HIV: results from a prospective observational cohort study at routine prevention of mother-to-child transmission sites, South Africa. J Acquir Immune Defic Syndr. 2009;50:521-528.
40. Taha TE, Kumwenda J, Cole SR, et al. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. J Infect Dis. 2009;200: 1490-1497.
41. Bedri A, Gudetta B, Isehak A, et al. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet. 2008;372:300-313.
42. Chasela CS, Hudgens MG, Jamieson DJ, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med. 2010;362: 2271-2281.
43. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008;359:119-129.
44. United Nations Children's Fund (UNICEF). Information by Country-South Africa Statistics; 2010. Available at: http://www.unicef.org/infobycountry/southafrica-statistics.html#80. Accessed November 19, 2013.
45. Rollins N, Mzolo S, Moodley T, et al. Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings. AIDS. 2009;23:1851-1857.
46. Ciaranello AL, Park JE, Ramirez-Avila L, et al. Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions. BMC Med. 2011;9:59.
47. Hall P, Wilson SR. Two guidelines for bootstrap hypothesis testing. Biometrics. 1991;47:757-762.
48. Zijenah LS, Moulton LH, Iliff P, et al. Timing of mother-to-child transmission of HIV-1 and infant mortality in the first 6 months of life in Harare, Zimbabwe. AIDS. 2004;18:273-280.
49. Persaud D, Gay H, Ziemniak C, et al. Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med. 2013;369: 1828-1835.
50. Kuhn L, Steketee RW, Weedon J, et al. Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study. J Infect Dis. 1999;179: 52-58.
51. Mayaux MJ, Burgard M, Teglas JP, et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA. 1996;275:606-610.
52. Joint United Nations Programme on HIV/AIDS (UNAIDS). Countdown to Zero: Global Plan Towards the Elimination of New HIV Infections Among Children by 2015 and Keeping Their Mothers Alive. Geneva, Switzerland; 2011.
53. Buchanan AM, Nadjm B, Amos B, et al. Utility of rapid antibody tests to exclude HIV-1 infection among infants and children aged ,18 months in a low-resource setting. J Clin Virol. 2012;55:244-249.
54. Menzies NA, Homsy J, Chang Pitter JY, et al. Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings. Pediatr Infect Dis J. 2009;28:819-825.
55. Sherman GG, Lilian RR, Coovadia AH. The performance of 5 rapid HIV tests using whole blood in infants and children: selecting a test to achieve the clinical objective. Pediatr Infect Dis J. 2012;31:267-272.
56. Mugambi ML, Deo S, Kekitiinwa A, et al. Do diagnosis delays impact receipt of test results? Evidence from the HIV early infant diagnosis program in Uganda. PLoS One. 2013;8:e78891.
57. Lilian RR. Identifying Interventions to Improve Outcomes of the South African Prevention of Mother-to-Child Transmission Programme [Dissertation]. Johannesburg, South Africa: Faculty of Health Sciences, University of the Witwatersrand; 2013.